Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Non-Current Deffered Revenue (2020 - 2021)

Historic Non-Current Deffered Revenue for GeneDx Holdings (WGS) over the last 2 years, with Q2 2021 value amounting to $295.0 million.

  • GeneDx Holdings' Non-Current Deffered Revenue changed N/A to $295.0 million in Q2 2021 from the same period last year, while for Jun 2021 it was $295.0 million, marking a year-over-year change of. This contributed to the annual value of $132.0 million for FY2020, which is N/A changed from last year.
  • Latest data reveals that GeneDx Holdings reported Non-Current Deffered Revenue of $295.0 million as of Q2 2021.
  • GeneDx Holdings' Non-Current Deffered Revenue's 5-year high stood at $297.0 million during Q1 2021, with a 5-year trough of $15.5 million in Q3 2020.